Ferring sells US royalties rights to Royalty Pharma
Ferring Pharmaceuticals has entered into an agreement with investment firm Royalty Pharma that triggers an upfront payment and potential milestone payments to the pharmaceutical company.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ferring gets cancer nod from FDA
For subscribers